Psychiatry and Clinical Psychopharmacology
Case Report

Methylenedioxymethamphetamine (MDMA)-induced toxic leukoencephalopathy: a case report

1.

Neuropsychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center, Houston, TX, USA

2.

Department of Psychiatry and Behavioral Sciences, McGovern Medical School, Harris County Psychiatric Center, The University of Texas Health Science Center, Houston, TX, USA

Psychiatry and Clinical Psychopharmacology 2018; 28: 215-219
DOI: 10.1080/24750573.2017.1407562
Read: 1216 Downloads: 573 Published: 09 February 2021

In recent years, ecstasy has become a very popular recreational drug. To date, very little data is available regarding its toxic side effects. Specifically, reports relating ecstasy use to the clinical diagnosis of leukoencephalopathy are quite rare. In this report, we present an interesting case of a 33-year-old female with a recent history of ecstasy abuse who presented with delirium and cognitive impairment. In addition, we review published case reports that explore the connection between MDMA and leukoencephalopathy

Files
EISSN 2475-0581